IN THE NEWS: Dr. Deol on Collaboration in the Administration of CAR T-cell Therapy


Abhinav Deol, M.D., medical oncologist and member of the Bone Marrow & Stem Cell Transplant, Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Programs at Karmanos Cancer Institute, discusses the importance of communication and collaboration among transplant centers and physicians to ensure that patients are referred and planning begins for CAR T-cell therapy as early as possible.

Read the full article here.